Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

Aaron Rodgers sparks controversy with explosive claims about the AIDS pandemic—discover why medical experts are pushing back ...

This update covers the latest health sector developments, including Moderna's COVID-19 vaccine review, GSK's asthma drug FDA ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

Analysts have set 12-month price targets for Moderna, revealing an average target of $37.62, a high estimate of $70.00, and a ...

FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and ...

According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and, in most cases, resolve within a ...

Trump hopes to slash the NIH budget by 38%, or almost $18bn; cut NSF budget by $4.7bn, more than 50%, scrap nearly half of ...